BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16202525)

  • 1. Opioids: from analgesia to anti-hyperalgesia?
    Simonnet G
    Pain; 2005 Nov; 118(1-2):8-9. PubMed ID: 16202525
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hyperalgesia properties of buprenorphine.
    Russo MA
    Pain; 2006 May; 122(1-2):216; author reply 216. PubMed ID: 16524662
    [No Abstract]   [Full Text] [Related]  

  • 3. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
    Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
    Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence.
    Ramasubbu C; Gupta A
    J Pain Palliat Care Pharmacother; 2011; 25(3):219-30. PubMed ID: 21834699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and central sensitisation: II. Induction and reversal of hyperalgesia.
    Ruscheweyh R; Sandkühler J
    Eur J Pain; 2005 Apr; 9(2):149-52. PubMed ID: 15737805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid tolerance and hyperalgesia.
    Chang G; Chen L; Mao J
    Med Clin North Am; 2007 Mar; 91(2):199-211. PubMed ID: 17321281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine for neuropathic pain--targeting hyperalgesia.
    Induru RR; Davis MP
    Am J Hosp Palliat Care; 2009 Dec-2010 Jan; 26(6):470-3. PubMed ID: 19666890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine: considerations for pain management.
    Johnson RE; Fudala PJ; Payne R
    J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 11. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning.
    Colpaert FC; Deseure K; Stinus L; Adriaensen H
    J Pharmacol Exp Ther; 2006 Feb; 316(2):892-9. PubMed ID: 16254131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative considerations for "new" kids on the opioid block.
    Moyo J; Rashiq S
    Can J Anaesth; 2011 May; 58(5):417-9, 419-22. PubMed ID: 21350889
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and central sensitisation: I. Preemptive analgesia.
    Sandkühler J; Ruscheweyh R
    Eur J Pain; 2005 Apr; 9(2):145-8. PubMed ID: 15737804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current knowledge of buprenorphine and its unique pharmacological profile.
    Pergolizzi J; Aloisi AM; Dahan A; Filitz J; Langford R; Likar R; Mercadante S; Morlion B; Raffa RB; Sabatowski R; Sacerdote P; Torres LM; Weinbroum AA
    Pain Pract; 2010; 10(5):428-50. PubMed ID: 20492579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selenium compound (selol) on the opioid activity in vincristine induced hyperalgesia.
    Bujalska M; Gumułka SW
    Neuro Endocrinol Lett; 2008 Aug; 29(4):552-7. PubMed ID: 18766156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Opioid analgesia prevents sensitization of neurons. Do opioids delete pain memory?].
    MMW Fortschr Med; 2003 May; 145(18):53. PubMed ID: 12838907
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of opioids for chronic pain: a review of the evidence.
    Ballantyne JC; Shin NS
    Clin J Pain; 2008; 24(6):469-78. PubMed ID: 18574357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine.
    Foster B; Twycross R; Mihalyo M; Wilcock A
    J Pain Symptom Manage; 2013 May; 45(5):939-49. PubMed ID: 23648060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.